Global Single-Use Gastroscopes Market Set to Reach USD 807.8 Million by 2033 at a 15.6% of CAGR

Single-use Gastroscopes market

The global single-use gastroscopes market is projected to expand significantly over the next decade, reaching an estimated valuation of US$ 807.8 million by 2033, up from US$ 167.2 million in 2022. This rapid growth is driven by the rising preference for single-use gastroscopes, primarily to mitigate infection risks associated with reusable devices in endoscopic procedures.

FMI’s report underscores several key factors propelling this expansion, including advancements in medical technology, increasing awareness about healthcare-associated infections, and the demand for improved patient safety protocols. With healthcare providers prioritizing infection control and efficiency, single-use gastroscopes are gaining traction as a cost-effective and safer alternative, particularly in high-demand clinical settings.

Single-use gastroscopes are endoscopes that are designed to be used only once and then disposed of, rather than being cleaned and reprocessed for multiple uses. These devices are used to examine the inside of stomach and intestines, and can be used to diagnose a variety of gastrointestinal conditions, such as ulcers, tumors, and inflammation.

Single-use gastroscopes are typically used for diagnostic procedures such as upper GI endoscopies or colonoscopies. The devices are inserted into the patient’s gastrointestinal tract to examine the lining of the esophagus, stomach, and intestines. The gastroscopes include a light source, a camera, and other tools for taking biopsies or removing polyps.

Single-use gastroscopes are available from a range of manufacturers and may vary in design and specifications. They are typically marketed as sterile and single-use only, and should not be reused. The devices should be disposed of in accordance with local regulations for medical waste.

Key Insights from FMI’s Single-Use Gastroscopes Market Survey:

• Market Value and Growth: The single-use gastroscopes market is anticipated to grow at a robust rate, with heightened adoption across hospitals and ambulatory surgical centers due to infection-control advantages.
• Technological Advancements: The development of high-performance single-use gastroscopes with enhanced image quality and ergonomic designs is improving procedural efficiency and supporting broader adoption across diverse healthcare settings.
• Regional Market Trends: North America and Europe currently lead the market, backed by strong healthcare infrastructure and regulatory emphasis on infection control, while Asia-Pacific is expected to witness significant growth due to the rising investment in healthcare and increased awareness of patient safety.

Key Takeaways:

• GERD is the leading segment as application among patients and professionals, and held about 34.5% market share in 2022, gastroscopes allow doctors to directly visualize the inside of the esophagus and stomach, and to take biopsies or remove small tissue samples for further testing.
• By end user, the hospitals dominated the global Single-Use Gastroscopes market withholding the total market share of about 46.4% by the end of 2022, owing to the convenience and ease of accessibility to new technological advanced applications.
• By region, North America is leading in the global Single-Use Gastroscopes market with U.S. contributing around 94.5% value share to the regional market in 2022

“Increasing adoption of Single-Use Gastroscopes and growing awareness and diagnosis of the gastrointestinal diseases to create lucrative potential for the market to grow,” says an analyst at Future Market Insights (FMI).

Future Outlook

The global single-use gastroscopes market is positioned for accelerated growth as healthcare providers increasingly turn to disposable solutions to enhance patient safety and streamline procedures. FMI’s report anticipates continued innovation and investment in single-use gastroscope technologies, which will likely support improved patient outcomes and further adoption in healthcare facilities worldwide.

Competitive Landscape

Key players in the market are focused on increase their product portfolio to strengthen their position in the single-use gastroscopes market, and also to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain competitive edge in the market are the pricing strategies, market strategies, technological advancements, regulatory compliance and acquisition & distribution agreement of other companies to expand their business.

For instance:

• In February 2022, Ambu declares that the Ambu aBo 2 and Ambu aScope Gastro have been given 510(k) regulatory approval in the US. The aScope Gastro, Ambu’s first sterile single-use gastroscope, combines state-of-the-art display and processing technology with new advanced imaging features.
• In January 2023, Fujifilm India announced the addition of two additional endoscopic solutions to its lineup: ClutchCutter and FushKnife. The goods were displayed at the 63rd annual meeting of the Indian Society of Gastroenterology, ISGCON, in Jaipur.

Key Companies Profiled

Ambu A/S; Boston Scientific Corporation; Fujifilm Holdings Corporation; HOYA Corporation; Olympus Corporation; Pentax Medical; KARL STORZ SE & Co. KG; Medtronic; Cook Medical; Richard Wolf GmbH; OBP Medical Corporation; Hill Rom Holdings; Parburch Medical; Flexicare Medical Ltd.; AirStrip Technologies

A Detailed Full Report

Key Segments Covered in Single-use Gastroscopes Industry Research

By Application:

• GERD
• Chronic Gastritis
• Gastric Ulcers
• Barrett’s Esophagus
• Others

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Diagnostic Centers

By Region:

• North America
• Latin America
• East Asia
• South Asia & Pacific
• Western Europe
• Eastern Europe
• Central Asia
• Russia & Belarus
• Balkan & Baltic Countries
• Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube